Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Evolus, Inc. (EOLS) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Evolus, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1570562.
Total stock buying since 2018: $54,298,322.
Total stock sales since 2018: $289,660,850.
Total stock option exercises since 2018: $2,228,659.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 50,000 | $393,480 | 323,244 | $3,744,841 | 0 | $0 |
| 2024 | 0 | $0 | 695,540 | $9,055,716 | 331,218 | $2,128,660 |
| 2023 | 174,967 | $1,296,505 | 5,955,470 | $48,994,980 | 0 | $0 |
| 2022 | 40,000 | $379,826 | 790,097 | $8,520,725 | 0 | $0 |
| 2021 | 775,086 | $8,467,966 | 2,915,038 | $28,054,699 | 0 | $0 |
| 2020 | 0 | $0 | 39,442 | $422,266 | 0 | $0 |
| 2019 | 1,971,889 | $37,938,293 | 6,609,253 | $127,213,191 | 10,020 | $99,999 |
| 2018 | 378,811 | $5,822,252 | 3,323,888 | $63,654,432 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 30,000 | $204,480 | 5,722 | $42,972 | 0 | $0 |
| 2025-06 | 20,000 | $189,000 | 127,905 | $1,283,192 | 0 | $0 |
| 2025-05 | 0 | $0 | 25,666 | $254,219 | 0 | $0 |
| 2025-03 | 0 | $0 | 163,951 | $2,164,458 | 0 | $0 |
| 2024-09 | 0 | $0 | 3,276 | $49,074 | 0 | $0 |
| 2024-08 | 0 | $0 | 5,631 | $89,251 | 0 | $0 |
| 2024-06 | 0 | $0 | 478,932 | $6,102,901 | 331,218 | $2,128,660 |
| 2024-05 | 0 | $0 | 60,276 | $771,714 | 0 | $0 |
| 2024-03 | 0 | $0 | 136,077 | $1,894,334 | 0 | $0 |
| 2024-02 | 0 | $0 | 11,348 | $148,442 | 0 | $0 |
| 2023-12 | 0 | $0 | 82,648 | $822,412 | 0 | $0 |
| 2023-10 | 0 | $0 | 1,690,663 | $12,679,972 | 0 | $0 |
| 2023-09 | 0 | $0 | 3,178 | $30,826 | 0 | $0 |
| 2023-08 | 174,967 | $1,296,505 | 19,200 | $197,182 | 0 | $0 |
| 2023-03 | 0 | $0 | 85,227 | $721,791 | 0 | $0 |
| 2023-02 | 0 | $0 | 4,037,511 | $34,133,843 | 0 | $0 |
| 2023-01 | 0 | $0 | 37,043 | $408,954 | 0 | $0 |
| 2022-10 | 0 | $0 | 38,304 | $344,429 | 0 | $0 |
| 2022-09 | 40,000 | $379,826 | 521,000 | $5,365,995 | 0 | $0 |
| 2022-08 | 0 | $0 | 26,000 | $345,358 | 0 | $0 |
| 2022-05 | 0 | $0 | 133,838 | $1,763,341 | 0 | $0 |
| 2022-03 | 0 | $0 | 70,955 | $701,602 | 0 | $0 |
| 2021-09 | 0 | $0 | 2,597,475 | $24,676,012 | 0 | $0 |
| 2021-08 | 775,086 | $8,467,966 | 301,156 | $3,256,293 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | Yamagishi-dressler Tomoko (Chief Marketing Officer) | Sale | 5,722 | 7.51 | 42,972 |
| 2025-08-15 | Stewart Brady (Director) | Buy | 30,000 | 6.82 | 204,480 |
| 2025-06-16 | Moatazedi David (See Remarks) | Sale | 16,582 | 9.89 | 164,062 |
| 2025-06-13 | Moatazedi David (See Remarks) | Sale | 111,323 | 10.05 | 1,119,130 |
| 2025-06-09 | White Albert G Iii (Director) | Buy | 20,000 | 9.45 | 189,000 |
| 2025-05-13 | Beaver Sandra (Chief Financial Officer) | Sale | 6,494 | 10.02 | 65,069 |
| 2025-05-12 | Moatazedi David (See Remarks) | Sale | 15,787 | 9.87 | 155,754 |
| 2025-05-12 | Avelar Rui (See Remarks) | Sale | 3,385 | 9.87 | 33,396 |
| 2025-03-27 | Moatazedi David (See Remarks) | Sale | 6,251 | 12.40 | 77,512 |
| 2025-03-18 | Yamagishi-dressler Tomoko (Chief Marketing Officer) | Sale | 4,536 | 13.26 | 60,124 |
| 2025-03-18 | Beaver Sandra (Chief Financial Officer) | Sale | 8,996 | 13.26 | 119,241 |
| 2025-03-18 | Moatazedi David (See Remarks) | Sale | 103,376 | 13.26 | 1,370,248 |
| 2025-03-18 | Avelar Rui (See Remarks) | Sale | 27,904 | 13.26 | 369,867 |
| 2025-03-12 | Parschauer Karah Herdman (Director) | Sale | 12,888 | 12.99 | 167,466 |
| 2024-09-06 | Beaver Sandra (Chief Financial Officer) | Sale | 3,276 | 14.98 | 49,074 |
| 2024-08-30 | Yamagishi-dressler Tomoko (Chief Marketing Officer) | Sale | 5,631 | 15.85 | 89,251 |
| 2024-06-06 | Moatazedi David (See Remarks) | Sale | 175,940 | 12.59 | 2,214,556 |
| 2024-06-06 | Moatazedi David (See Remarks) | Option Ex | 175,940 | 7.28 | 1,280,843 |
| 2024-06-05 | Moatazedi David (See Remarks) | Sale | 155,278 | 12.92 | 2,006,502 |
| 2024-06-05 | Moatazedi David (See Remarks) | Option Ex | 155,278 | 5.46 | 847,817 |
| 2024-06-04 | Moatazedi David (See Remarks) | Sale | 140,214 | 12.73 | 1,784,643 |
| 2024-06-03 | Malik Vikram (Director) | Sale | 7,500 | 12.96 | 97,200 |
| 2024-05-14 | Gill David N (Director) | Sale | 6,718 | 12.60 | 84,653 |
| 2024-05-13 | Malik Vikram (Director) | Sale | 28,000 | 12.93 | 362,012 |
| 2024-05-13 | Gill David N (Director) | Sale | 3,643 | 12.72 | 46,357 |
| 2024-05-10 | Beaver Sandra (Chief Financial Officer) | Sale | 2,423 | 12.72 | 30,813 |
| 2024-05-10 | Moatazedi David (See Remarks) | Sale | 16,051 | 12.72 | 204,120 |
| 2024-05-10 | Avelar Rui (See Remarks) | Sale | 3,441 | 12.72 | 43,759 |
| 2024-03-27 | Moatazedi David (See Remarks) | Sale | 6,236 | 13.86 | 86,430 |
| 2024-03-19 | Beaver Sandra (Chief Financial Officer) | Sale | 5,672 | 13.92 | 78,976 |
| 2024-03-19 | Moatazedi David (See Remarks) | Sale | 96,566 | 13.92 | 1,344,584 |
| 2024-03-19 | Avelar Rui (See Remarks) | Sale | 27,603 | 13.92 | 384,344 |
| 2024-02-22 | Beaver Sandra (Chief Financial Officer) | Sale | 1,821 | 13.08 | 23,820 |
| 2024-02-22 | Moatazedi David (See Remarks) | Sale | 7,706 | 13.08 | 100,802 |
| 2024-02-22 | Avelar Rui (See Remarks) | Sale | 1,821 | 13.08 | 23,820 |
| 2023-12-08 | Moatazedi David (See Remarks) | Sale | 31,300 | 9.73 | 304,517 |
| 2023-12-06 | Moatazedi David (See Remarks) | Sale | 51,348 | 10.09 | 517,895 |
| 2023-10-16 | Medytox Inc. | Sale | 1,690,663 | 7.50 | 12,679,972 |
| 2023-09-06 | Beaver Sandra (Chief Financial Officer) | Sale | 3,178 | 9.70 | 30,826 |
| 2023-08-16 | Beaver Sandra (Chief Financial Officer) | Sale | 2,211 | 10.27 | 22,706 |
| 2023-08-16 | Moatazedi David (See Remarks) | Sale | 14,778 | 10.27 | 151,770 |
| 2023-08-16 | Avelar Rui (See Remarks) | Sale | 2,211 | 10.27 | 22,706 |
| 2023-08-15 | Malik Vikram (Director) | Buy | 174,967 | 7.41 | 1,296,505 |
| 2023-03-27 | Moatazedi David (See Remarks) | Sale | 6,110 | 8.47 | 51,751 |
| 2023-03-14 | Moatazedi David (See Remarks) | Sale | 64,211 | 8.47 | 543,802 |
| 2023-03-14 | Avelar Rui (See Remarks) | Sale | 14,906 | 8.47 | 126,238 |
| 2023-02-07 | Medytox Inc. | Sale | 2,187,511 | 8.50 | 18,593,843 |
| 2023-02-01 | Alphaeon 1 Llc | Sale | 1,850,000 | 8.40 | 15,540,000 |
| 2023-01-20 | Medytox Inc. | Sale | 37,043 | 11.04 | 408,954 |
| 2022-10-06 | Medytox Inc. | Sale | 38,304 | 8.99 | 344,429 |
| 2022-09-15 | Medytox Inc. | Sale | 72,000 | 10.34 | 744,333 |
| 2022-09-14 | Medytox Inc. | Sale | 219,000 | 10.27 | 2,249,130 |
| 2022-09-12 | Hayman Robert | Buy | 1,091 | 10.78 | 11,755 |
| 2022-09-09 | Medytox Inc. | Sale | 20,700 | 10.53 | 217,908 |
| 2022-09-09 | Hayman Robert | Buy | 8,909 | 10.35 | 92,181 |
| 2022-09-08 | Medytox Inc. | Sale | 15,300 | 10.39 | 158,982 |
| 2022-09-06 | Blank Simone | Buy | 20,000 | 9.24 | 184,840 |
| 2022-09-06 | Farrell Peter C | Buy | 10,000 | 9.11 | 91,050 |
| 2022-08-01 | Medytox Inc. | Sale | 26,000 | 13.28 | 345,358 |
| 2022-05-18 | Silvernail Lauren P (See Remarks) | Sale | 52,015 | 12.42 | 646,026 |
| 2022-05-17 | Silvernail Lauren P (See Remarks) | Sale | 16,189 | 13.92 | 225,350 |
| 2022-05-16 | Moatazedi David (See Remarks) | Sale | 55,321 | 13.63 | 754,301 |
| 2022-05-16 | Gill David N | Sale | 5,000 | 13.62 | 68,080 |
| 2022-05-13 | Gill David N | Sale | 5,313 | 13.10 | 69,584 |
| 2022-03-28 | Moatazedi David (See Remarks) | Sale | 6,104 | 11.62 | 70,928 |
| 2022-03-08 | Muilenburg Crystal (Chief Marketing Officer) | Sale | 6,495 | 9.72 | 63,163 |
| 2022-03-08 | Moatazedi David (See Remarks) | Sale | 37,972 | 9.72 | 369,277 |
| 2022-03-08 | Avelar Rui (See Remarks) | Sale | 10,192 | 9.72 | 99,117 |
| 2022-03-08 | Silvernail Lauren P (See Remarks) | Sale | 10,192 | 9.72 | 99,117 |
| 2021-09-01 | Alphaeon 1 Llc | Sale | 2,597,475 | 9.50 | 24,676,012 |
| 2021-08-27 | Medytox Inc. | Buy | 51,000 | 10.93 | 557,583 |
| 2021-08-26 | Medytox Inc. | Buy | 66,000 | 11.02 | 727,386 |
| 2021-08-25 | Medytox Inc. | Buy | 44,000 | 11.12 | 489,368 |
| 2021-08-24 | Medytox Inc. | Buy | 72,219 | 11.18 | 807,047 |
| 2021-08-23 | Medytox Inc. | Buy | 69,781 | 11.03 | 769,754 |
| 2021-08-23 | Malik Vikram | Sale | 26,077 | 10.99 | 286,716 |
| 2021-08-20 | Medytox Inc. | Buy | 48,000 | 10.56 | 506,687 |
| 2021-08-20 | Malik Vikram | Sale | 49,878 | 10.61 | 529,305 |
| 2021-08-19 | Medytox Inc. | Buy | 55,000 | 10.51 | 578,105 |
| 2021-08-19 | Malik Vikram | Sale | 11,962 | 10.50 | 125,553 |
| 2021-08-18 | Medytox Inc. | Buy | 45,000 | 10.54 | 474,075 |
| 2021-08-18 | Malik Vikram | Sale | 25,000 | 10.44 | 261,025 |
| 2021-08-17 | Medytox Inc. | Buy | 70,000 | 10.69 | 748,090 |
| 2021-08-17 | Malik Vikram | Sale | 42,083 | 10.06 | 423,565 |
| 2021-08-16 | Medytox Inc. | Buy | 65,000 | 11.34 | 737,035 |
| 2021-08-16 | Moatazedi David (See Remarks) | Sale | 47,737 | 11.35 | 541,719 |
| 2021-08-13 | Medytox Inc. | Buy | 63,757 | 11.04 | 701,769 |
| 2021-08-13 | Moatazedi David (See Remarks) | Sale | 22,708 | 10.66 | 242,067 |
| 2021-08-12 | Medytox Inc. | Buy | 62,126 | 10.96 | 680,495 |
| 2021-08-11 | Medytox Inc. | Buy | 26,160 | 10.77 | 281,743 |
| 2021-08-10 | Muilenburg Crystal (Chief Marketing Officer) | Sale | 5,362 | 11.18 | 59,941 |
| 2021-08-10 | Moatazedi David (See Remarks) | Sale | 41,763 | 11.18 | 466,826 |
| 2021-08-10 | Avelar Rui (See Remarks) | Sale | 14,293 | 11.18 | 159,795 |
| 2021-08-10 | Silvernail Lauren P (See Remarks) | Sale | 14,293 | 11.18 | 159,781 |
| 2021-01-25 | Jafar Michael M. (See Remarks) | Sale | 2,699 | 7.46 | 20,134 |
| 2021-01-25 | Moatazedi David (See Remarks) | Sale | 8,310 | 7.46 | 61,992 |
| 2021-01-25 | Avelar Rui (See Remarks) | Sale | 2,699 | 7.46 | 20,134 |
| 2021-01-25 | Silvernail Lauren P (See Remarks) | Sale | 2,699 | 7.46 | 20,134 |
| 2020-01-07 | Avelar Rui (See Remarks) | Sale | 39,442 | 10.71 | 422,266 |
| 2019-12-10 | Avelar Rui (See Remarks) | Option Ex | 10,020 | 9.98 | 99,999 |
| 2019-06-13 | Gill David N | Buy | 2,000 | 13.65 | 27,300 |
| 2019-06-03 | Malik Vikram | Buy | 1,298,701 | 19.25 | 24,999,994 |
| 2019-06-03 | Alphaeon Corp (10% Owner) | Sale | 1,298,701 | 19.25 | 24,999,994 |
| 2019-05-31 | Silvernail Lauren P (See Remarks) | Sale | 2,612 | 13.54 | 35,353 |
| 2019-05-29 | Romine Kristine | Buy | 2,090 | 14.77 | 30,863 |
| 2019-05-22 | Alphaeon Corp (10% Owner) | Sale | 290,518 | 19.25 | 5,592,471 |
| 2019-05-20 | Romine Kristine | Buy | 40,562 | 19.25 | 780,818 |
| 2019-05-20 | Alphaeon Corp (10% Owner) | Sale | 5,017,422 | 19.25 | 96,585,373 |
| 2019-05-20 | Blank Simone | Buy | 628,536 | 19.25 | 12,099,318 |
| 2018-12-17 | Malik Vikram | Buy | 7,800 | 13.04 | 101,688 |
| 2018-12-17 | Romine Kristine | Buy | 5,000 | 12.75 | 63,750 |
| 2018-12-14 | Romine Kristine | Buy | 11,000 | 12.50 | 137,456 |
| 2018-12-14 | Gill David N | Buy | 3,000 | 12.77 | 38,301 |
| 2018-11-29 | Romine Kristine | Buy | 6,347 | 14.00 | 88,858 |
| 2018-11-29 | Alphaeon Corp (10% Owner) | Sale | 573,888 | 14.00 | 8,034,432 |
| 2018-11-29 | Blank Simone | Buy | 295,024 | 14.00 | 4,130,336 |
| 2018-09-14 | Jafar Michael M. (Chief Marketing Officer) | Buy | 12,800 | 20.83 | 266,585 |
| 2018-09-11 | Alphaeon Corp (10% Owner) | Sale | 1,750,000 | 21.04 | 36,820,000 |
| 2018-08-22 | Romine Kristine | Buy | 10,000 | 19.83 | 198,270 |
| 2018-07-23 | Alphaeon Corp | Sale | 1,000,000 | 18.80 | 18,800,000 |
| 2018-06-14 | Malik Vikram | Buy | 8,600 | 28.88 | 248,350 |
| 2018-06-08 | Romine Kristine | Buy | 2,000 | 28.05 | 56,100 |
| 2018-06-07 | Romine Kristine | Buy | 200 | 33.40 | 6,680 |
| 2018-06-06 | Hau Bosun | Buy | 2,898 | 34.94 | 101,256 |
| 2018-06-04 | Hau Bosun | Buy | 7,142 | 29.19 | 208,474 |
| 2018-06-01 | Romine Kristine | Buy | 4,000 | 25.74 | 102,948 |
| 2018-05-31 | Romine Kristine | Buy | 3,000 | 24.40 | 73,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of EOLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Evolus, Inc. (symbol EOLS, CIK number 1570562) see the Securities and Exchange Commission (SEC) website.